Immunovant, a clinical-stage biopharmaceutical company, has been making headlines with recent insider trading activities, SEC filings, and analyst opinions. This…
Read More »Biotech
Predictive Oncology (NASDAQ: POAI) has seen a significant surge in its stock price, driven by the announcement of positive results…
Read More »
Insmed (NASDAQ: INSM) has recently been in the spotlight following a significant surge in its stock price. This rise is…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »
Bicycle Therapeutics Plc (NASDAQ: BCYC) is making headlines with a significant pre-market surge, driven by a series of strategic moves…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…
Read More »
Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…
Read More »
ELEVAI Labs established two subsidiaries: ELEVAI Biosciences, Inc., and ELEVAI Skincare, Inc. ELEVAI Biosciences will focus on acquiring and developing…
Read More »
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »
The company’s international distribution agreements have a contracted cumulative minimum purchase requirement of up to $4.9 million over the first…
Read More »